Related Experiment Video
Updated: Mar 7, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment
Ryo Sato1, Teppei Nakano2, Mari Hosonaga3
1Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan; Department of Respiratory Medicine, Kumamoto University, Kumamoto, Japan.
Abstract:
Metastasis is the main cause of treatment failure and death in cancer patients. Metastasis of tumor cells to the brain occurs frequently in individuals with breast cancer, non-small cell lung cancer, or melanoma. Despite recent advances in our understanding of the causes and in the treatment of primary tumors, the biological and molecular mechanisms underlying the metastasis of cancer cells to the brain have remained unclear. Metastasizing cancer cells interact with their microenvironment in the brain to establish metastases. We have now developed mouse models of brain metastasis based on intracardiac injection of human breast cancer or melanoma cell lines, and we have performed RNA sequencing analysis to identify genes in mouse brain tissue and the human cancer cells whose expression is associated specifically with metastasis. We found that the expressions of the mouse genes Tph2, Sspo, Ptprq, and Pole as well as those of the human genes CXCR4, PLLP, TNFSF4, VCAM1, SLC8A2, and SLC7A11 were upregulated in brain tissue harboring metastases. Further characterization of such genes that contribute to the establishment of brain metastases may provide a basis for the development of new therapeutic strategies and consequent improvement in the prognosis of cancer patients.
Insights
Researchers identified key genes involved in cancer cells spreading to the brain. Understanding these gene expressions may lead to new treatments for brain metastases, improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Neuroscience
Background:
- Cancer metastasis, particularly to the brain, is a primary driver of mortality and treatment failure.
- Brain metastasis frequently affects patients with breast cancer, non-small cell lung cancer, and melanoma.
- The precise molecular mechanisms enabling cancer cells to establish in the brain remain largely unknown.
Purpose of the Study:
- To elucidate the molecular mechanisms of brain metastasis.
- To identify specific genes upregulated in brain metastases using mouse models.
- To lay the groundwork for novel therapeutic strategies against brain metastasis.
Main Methods:
- Development of mouse models for brain metastasis via intracardiac injection of human cancer cell lines (breast cancer, melanoma).
- RNA sequencing analysis of mouse brain tissue and human cancer cells within the metastatic microenvironment.
- Identification of differentially expressed genes in metastatic versus non-metastatic conditions.
Main Results:
- Upregulation of specific mouse genes (Tph2, Sspo, Ptprq, Pole) in brain tissue with metastases.
- Upregulation of specific human genes (CXCR4, PLLP, TNFSF4, VCAM1, SLC8A2, SLC7A11) in metastatic cancer cells within the brain.
- Identification of a distinct gene expression signature associated with brain metastasis.
Conclusions:
- Specific host and cancer cell genes are significantly altered during brain metastasis.
- These identified genes represent potential therapeutic targets for treating brain metastases.
- Further research into these genes could improve the prognosis for cancer patients with brain metastasis.
Related Concept Videos
02:17The Tumor Microenvironment
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...